Ventilatory effects of low-dose paraoxon result from central muscarinic effects

Pascal Houze1, Laetita Pronzola, Maya Kayouka

  • 1Toxicology Laboratory, Faculty of Pharmacy, 75006 Paris, France.

Insights

Low-dose paraoxon causes respiratory toxicity by affecting the central nervous system. Atropine, which crosses the blood-brain barrier, reversed these effects, indicating a central origin for paraoxon

Area of Science:

  • Toxicology
  • Neuroscience
  • Respiratory Physiology

Background:

  • Paraoxon is an organophosphate pesticide known to induce respiratory toxicity.
  • Atropine effectively reverses parathion and paraoxon-induced respiratory toxicity.
  • The precise origin (peripheral or central) of paraoxon's ventilatory effects requires further investigation.

Purpose of the Study:

  • To determine whether the ventilatory effects of low-dose paraoxon originate in the peripheral or central nervous system.
  • To investigate the role of muscarinic signaling in paraoxon-induced respiratory toxicity.

Main Methods:

  • Male Sprague-Dawley rats were administered low-dose paraoxon (0.215 mg/kg).
  • Animals were treated with atropine (10 mg/kg) or escalating doses of methylatropine (5.42 to 542 mg/kg).
  • Ventilation was assessed using whole-body plethysmography, and body temperature was monitored via infra-red telemetry.

Main Results:

  • Paraoxon induced hypothermia, partially reversed by atropine but not methylatropine.
  • Paraoxon decreased respiratory rate by increasing expiratory time and tidal volume.
  • Atropine completely reversed paraoxon's ventilatory effects, while methylatropine showed no significant effect even at high doses.

Conclusions:

  • The ventilatory effects of low-dose paraoxon are primarily mediated by the central nervous system.
  • Disrupted muscarinic signaling within the central nervous system is the likely mechanism of paraoxon-induced respiratory toxicity.
  • Atropine's ability to reverse these effects highlights its efficacy in counteracting central neurotoxic effects of organophosphates.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Chemical Factors Affecting Respiration Centers01:31

Chemical Factors Affecting Respiration Centers

Chemical factors such as changing CO2, O2, and H+ levels in arterial blood play a critical role in influencing respiration depth and rates. These variations are detected by chemoreceptors—specialized sensors located in two primary body areas. Central chemoreceptors are found throughout the brain stem, including the ventrolateral medulla, while peripheral chemoreceptors are located in the aortic arch and carotid arteries.
CO2 has a potent influence on respiration and is strictly regulated. Under...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...